Literature DB >> 1353370

50 kD prolactin binding protein in schizophrenics on neuroleptic medication.

A M Walker1, C A Peabody, T W Ho, M D Warner.   

Abstract

Serum samples from 15 age-matched normal male subjects and 15 male schizophrenic patients on neuroleptic medication were subjected to immunoprecipitation with anti-human prolactin (PRL) and analysis of the immunoprecipitate by two-dimensional gel electrophoresis. We report the unexpected immunoprecipitation of large amounts of an approximately 50 kD protein in 12/15 of the schizophrenic patients. Preliminary analyses suggest that this 50 kD protein may be an IgG heavy chain. Since total levels of IgG and each of the IgG subclasses are the same in the normal and schizophrenic group, the increased amount of the 50 kD protein in the schizophrenics is clearly specific to anti PRL precipitation. Since the anti-PRL does not directly recognize either the 50 kD protein or any immunoglobulin light chains in the precipitate, we suggest that the 50 kD protein is precipitated because it is bound to PRL. Perhaps immunoglobulin binding of PRL is a mechanism used to compensate for chronically elevated PRL levels during neuroleptic treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353370      PMCID: PMC1188402     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  17 in total

1.  Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone.

Authors:  N H Farkouh; M G Packer; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

2.  Glycosylated and nonglycosylated prolactin in serum during pregnancy.

Authors:  E Markoff; D W Lee; D R Hollingsworth
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

3.  Differential isoform distribution between stored and secreted prolactin.

Authors:  W S Oetting; A M Walker
Journal:  Endocrinology       Date:  1986-09       Impact factor: 4.736

4.  A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

Authors:  B R Oakley; D R Kirsch; N R Morris
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

5.  Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line.

Authors:  R P Shiu; H P Elsholtz; T Tanaka; H G Friesen; P W Gout; C T Beer; R L Noble
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

6.  Preferential release of newly synthesized prolactin granules is the result of functional heterogeneity among mammotrophs.

Authors:  A M Walker; M G Farquhar
Journal:  Endocrinology       Date:  1980-10       Impact factor: 4.736

7.  Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice.

Authors:  D H Russell; K T Mills; F J Talamantes; H A Bern
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Human pituitary prolactin: isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities.

Authors:  F Nyberg; P Roos; L Wide
Journal:  Biochim Biophys Acta       Date:  1980-10-21

9.  Intracellular processing of prolactin.

Authors:  W S Oetting; A M Walker
Journal:  Endocrinology       Date:  1985-10       Impact factor: 4.736

Review 10.  Prolactin and neuroleptic drugs.

Authors:  A I Green; W A Brown
Journal:  Endocrinol Metab Clin North Am       Date:  1988-03       Impact factor: 4.741

View more
  1 in total

1.  Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

Authors:  A M Walker; D W Montgomery; S Saraiya; T W Ho; H S Garewal; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.